• Unlocking the financial promise of personalized medicine

    Helping the pharmaceutical and diagnostic industries understand how to leverage companion and other tests to achieve therapy goals.

  • Introducing Diaceutics DxExcellence Primer

    A web-based educational and training resource to accelerate personalized medicine success.

  • Is your team ready for personalized medicine?

    Find out -- take our online PM Readiness Test.

  • New Xalkori/Zelboraf Research Report

    A unique opportunity to explore the launch, reimbursement and adoption of two groundbreaking PM approvals.

Diaceutics Exclusive Leadership eBrief

Diaceutics returned to several of the companies analyzed in their 2011 Pharma Readiness for PM report and asked executive leaders about the current status of their company’s PM strategy.

  • CASE STUDY:
    HERCEPTIN
    Genentech

    How multiple areas of patient “leakage” in the diagnostic program led to the loss of patients and several billion dollars in prescriptions.

  • CASE STUDY:
    Epzicom
    GlaxoSmithKline

    The positive impact of taking a proactive approach to a targeted safety strategy.

  • CASE STUDY:
    Selzentry
    Pfizer

    A loose partnering strategy and exclusive diagnostic relationship causes a negative impact on therapy sales.

  • CASE STUDY:
    Tysabri
    Elan/Biogen Idec

    Post approval identification of the need for a diagnostic, handled correctly, can actually improve a drugs commercial success.

  • CASE STUDY:
    Xalkori
    Pfizer

    Smart choices in test technology leads to rapid adoption but test cost presents a major issue for payers and patients.

PM Insights

  • Join us for a complimentary webinar on June 6th
    PM 2.0 - An integrated approach to personalized medicine... Click Here
  • Mystery Solved! What is the...

    A virtual expert panel of 4... + More